New information helps assess the clinical impact of HAART.
Murphy
M J
MJ
D017088:AIDS-Related Opportunistic Infections / Q000401:mortality / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors